Waters & Kraus, LLP
Nationally defending mesothelioma victims against corporate greed.
Size of Organization: 42
Year Established: 1995Web Site: http://www.waterskraus.com
Toll Free: 800-226-9880
|Profile Visibility |
#372 in weekly profile views out of 280,906 total law firms Overall
Waters & Kraus, LLP is a mid-sized plaintiffs' firm with a successful national practice, as well as international experience. Our attorneys focus on toxic tort litigation (asbestos/mesothelioma), consumer product liability, as well as qui tam (whistleblower) and commercial litigation. With offices in Texas, California and Maryland, Waters & Kraus, LLP has litigated cases in jurisdictions across the United States on behalf of individuals from all 50 states, as well as foreign governments. To learn more about the firm and our practice, please go to www.waterskraus.com.
Martindale-Hubbell has augmented a firm's provided information with third-party sourced data to present a more comprehensive overview of the firm's expertise:
U.S. Federal Litigation Activity
Highest number of cases by Waters & Kraus, LLP:
Toxic Torts (52 cases in past two years)
Peer Review Ratings
Total number of Peer Review Rated lawyers of Waters & Kraus, LLP:
Documents by Waters & Kraus, LLP on Martindale.com
CRS-207 Receives Orphan Drug Status for Mesothelioma
Michael B. Gurien,Michael B. Gurien,Gary M. Paul,Gary M. Paul, April 22, 2015
CRS-207 has been granted orphan drug status by the U. S. Food and Drug Administration (FDA) for treatment of pleural mesothelioma patients. CRS-207, manufactured by Aduro Biotech, had previously been granted orphan drug designation for treatment of pancreatic cancer. The orphan drug designation is...
High Rates of Mesothelioma Found in Southern Nevada Residents
Michael B. Gurien,Gary M. Paul, April 22, 2015
Construction of Nevada highways has been delayed because of the discovery of high levels of asbestos in the soil. Scientists are concerned that the asbestos could be dangerous to residents living nearby. Asbestos exposure is the only confirmed cause of mesothelioma, an incurable cancer of the...
Mesothelioma Patients May Benefit From Lymphoma Drug
Peter A. Kraus,Troyce G. Wolf, April 22, 2015
Mesothelioma patients whose disease is of the epithelioid subtype may benefit from treatment with a drug that is already being used in patients with large cell lymphoma and Hodgkin’s disease. Adcetris — or brentuximab vedotin — has been shown in encouraging new research to slow...